The actos (OSPHERE) market is poised for significant growth, driven by several key factors. As of 2024, the global actos market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031, reaching a size of approximately USD 1.2 billion by 2031[1][4].
The actos market is segmented based on several key factors:
The actos market is characterized by the presence of several major players, including Novartis, Dr. Reddy's, Shire, and others.
Reddy's, Shire, and others, which offer competitiveARY products. These products promote and cater to new uses and seek to commercialize the active ingredients[1][4].
What is Actos?Actosis an anti-depressant medication primarily used to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase 4 (DPP 4) inhibitors. These medications work by increasing the levels of a vital protein (glycine
dopey) in the liver, which helps lower blood sugar levels in individuals with diabetes. Actos works by addressing how the body uses its cells, tissues, and organs, ultimately leading to improved diabetes control.
When taking Actos, rare but serious side effects can occur. These can include seizures, hallucinations, or even kidney problems. In some cases, individuals may even experience nerve damage as a result. It is important to seek medical attention immediately if you experience any of these symptoms.
is a medication used to manage type 2 diabetes by decreasing the amount of sugar the liver uses, which helps lower blood sugar levels and improve glycemic control. By lowering blood sugar levels, Actos can help individuals who have high blood sugar levels maintain a more balanced diet and exercise.
Actos is produced by Actavis LLC, a TADL pharmaceutical company specializing in gastrointestinal, cardiovascular, and diabetes medications. Actavis focuses on treating high blood sugar, a common condition associated with diabetes. Actos is available by prescription only and is prescribed to individuals with Type 2 diabetes in the U. S. among those who have a kidney problem or kidney disease. It works by preventing the action of aldehyde dehydrogenase, an enzyme responsible for breaking down proteins in the body.
Actos and other medications are dipeptides, which are used to manage and treat bacterial infections by preventing the growth of certain bacteria. This results in fewer bacterial infections and the prevention of complications like diarrhea or stomach pain. Other dipeptides like dextromethoxazol, amoxapine, and mazbloodo are also used to manage bacterial infections, although amoxicillin, a macrolide, is used primarily for amoebiasis management.
Actos and other medications can cause a range of side effects, which individuals can take to avoid or reduce their symptoms. Common side effects can include nausea, diarrhea, abdominal pain, and blood in the stool. Other potential side effects that individuals can experience include fatigue, mood changes, and changes in bowel habits or constipation. It is crucial to discuss with your healthcare provider if you are sensitive to any side effects with Actos.
It is important to note that Actos can interact with other medications and health conditions, so it is important to follow healthcare provider’s instructions for using the medication. Additionally, Actos can cause liver damage if taken with alcohol. Therefore, it is essential to avoid or limit the use of alcohol while taking Actos.
Actos should be used with caution in individuals with a history of certain heart conditions, liver disease, or kidney disease. It is recommended to follow the prescribed dosage and frequency of use to achieve the best blood sugar control while minimizing side effects.
Actos can be taken with or without food, but it is important to follow the dosage instructions provided by a healthcare provider. Typically, Actos is taken once daily, with or without food, three to four times daily. It is important to note that the medication may work for up to six weeks and may require a longer course of treatment to become fully effective. Once you finish treatment, it is important to continue taking the medication, which can be resistance or side effects that can occur.
As with any medication, Actos side effects can occur which may lead to resistance or resistance patterns.
Active Ingredients:Each tablet contains 60mg of actosalone.
Manufacturer:As an analogue of the well-known drug tamoxifen, this drug is also an antagonist at estrogen receptors.
Directions for Use:The recommended dose is one tablet taken every 12 hours. Do not exceed this dose in any 24-hour period. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. If you miss a dose, skip it and continue with your regular schedule in which the dosage schedule is included in the box. Do not take a double dose to make up for a missed dose.
Active Ingredient:Actosalone was approved for the treatment of type 2 diabetes in the US in 1999. In the UK, Actos is also used offlabel to control high blood sugar in adults and in children, along with a low dose of nintestick lipase inhibitor (Nintestick).
Warnings:Older formulations may have concerns about potential interactions with other medicines. Consult your healthcare provider before use. Keep all medicines out of the reach of children.
Side Effects:Some users have reported side effects such as nausea, breast pain and fever. Other less common side effects include headache, dizziness, abnormal vision, rash, or skin changes (i.e. blistering and peeling). If any severe side effects occur, stop use and seek medical help immediately.
Read More AboutActos and TamoxifenProductsDirections for UseWarningsSide EffectsWarningInteractionsContraindicationsSimilaritiesThe product on line 16.3mg contains the active substance actosalone as well as the parent drug tamoxifen. Do not take this product if you have a hypersensitivity (allergy) to any of its ingredients or to any of the other ingredients of this product. Contains alcohol and propylene glycol in a glass of cold water and should be kept away from children.Take this medication by mouth with or without food as directed by your doctor, usually once daily. Ingested actosalone may take longer to start working if you take it daily. If you miss a dose, continue with your regular dosing schedule. Do not increase your dose. Do not take the missed dose. Contact your healthcare provider if the treatment remains effective for more than 3 months. For full prescribing information, visit the US Food and Drug Administration (FDA) website: www.fda.gov/medwatch or call 1-800-332-1088 to toll-free. This product is available in the US, Europe and Canada.
SimilaricationsThe product on line 16.3mg contains the active substance actosalone and the other ingredients. Contains alcohol and propylene glycol in a glass of cold water. Do not use this medication for more than 3 months.By
A federal judge dismissed a lawsuit claiming the company, Actos Inc., failed to pay royalties on the diabetes-fighting drug Avandia.
The complaint said the company failed to warn patients that Avandia, a popular diabetes drug, could cause kidney disease.
The suit claimed that the company failed to disclose the potential link between Avandia and heart disease and that the company failed to provide the drug to patients who were taking it.
The court ordered the company to pay $2.2 million in compensatory and punitive damages to the plaintiffs. That amount will be paid by Actos until the company can demonstrate the damage to the plaintiffs, including to the company.
The lawsuit also alleged that the company failed to properly warn patients about the risks of the drug, including the drug's ability to raise the risk of bladder cancer.
In addition, the company failed to disclose the potential link between Avandia and heart disease.
In a previous ruling, the Supreme Court found that Actos failed to warn patients about the drug's dangers and failed to provide any information about the risk of bladder cancer.
The judge, however, dismissed the claims that the company failed to provide adequate warnings of the drug's risk of bladder cancer, but that the company failed to provide the warning.
The lawsuit alleges that the company failed to warn the public about the risks of Avandia, a popular diabetes drug that has been widely used for decades.
In a ruling that was released Thursday, the court also ordered the company to pay $5.9 million in compensatory damages to the plaintiffs.
A lawyer representing the plaintiff in the case has been appointed by the court to serve as its special assistant.
Actos is a subsidiary of Actos Inc., a company that is developing Avandia. The company said it is developing Avandia and will submit the case to the court.
The case was filed Monday in federal court in Boston, Massachusetts, where the company has offices.
The suit was brought by a Boston-based company, Avandia Pharmaceuticals, and a patient who sought to be compensated for the loss of her bladder cancer. The company was paying out royalties on the drug for the first four years of its existence.
A spokesman for the Avandia Pharmaceuticals subsidiary, however, said that Avandia Pharmaceuticals "is not a defendant in this case."
Actos was founded in the 1990s to sell and treat diabetes, but has since been discontinued in Europe and the United States.
Actos Inc. is still in the business of developing Avandia. The company said it is "evaluating the best course of action" for the company.
The company's stock was up 0.3 percent at Rs 10,000 after the settlement was reached. In January, the company announced a voluntary settlement with plaintiffs who claimed that the company failed to warn them of the risks of Avandia, but failed to provide adequate warnings.
In the settlement, the plaintiffs, who claimed that the company failed to warn patients about Avandia, agreed not to pay any royalties on Avandia's sales and marketing.
The lawsuit alleges that the company failed to provide the warning to patients and failed to warn doctors and pharmacists of the risks of Avandia, as well as to the company's own marketing.
The plaintiff in the case alleged that the company failed to warn consumers and the public that Avandia could cause kidney disease.
In addition to the $2.2 million in compensatory damages, the lawsuit claims that the company failed to warn patients about the potential link between Avandia and heart disease.
The suit said that the company failed to disclose the risk of heart disease, but that the company failed to provide adequate warnings to patients who were taking Avandia.
In a statement, the company said that the company has made "commercially sound and successful" settlements with the plaintiffs.
In a statement, the company said that the company is in a "competing position" with the federal government and has not paid any royalties.
The company said that the settlement and the case had not been made on the condition that the company "provide the appropriate compensation" to the plaintiffs.
The company also said that it is taking steps to protect the public and its members and customers by providing a consumer protection website.
Actos, a company in operation since 2006, said it has no plans to launch a generic version of Avandia in the near future.
Stade de France Pharmacy